XI’AN, PEOPLE’S REPUBLIC OF CHINA -- (MARKET WIRE) -- May 16, 2007 -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTCBB: HFGB), a rapidly growing Chinese company which produces raw materials for pharmaceutical and nutraceutical production, today reported results for the first quarter ended March 31, 2007. Revenue for the first quarter of 2007 increased 27% to USD $1,397,669 compared to USD $1,103,447 for the first quarter of 2006. Gross profit for the first quarter was USD $407,851, a 140% increase compared to USD $169,737 for the period ended March 31, 2006. Net income for the first quarter 2007 was $311,128, compared to net income of USD $127,298 in the first quarter of 2006, a 144% increase.
